Clinical Trial: Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia

U.S., July 21 -- ClinicalTrials.gov registry received information related to the study (NCT07712913) titled 'Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia' on June 18.

Brief Summary: Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia

Study Start Date: June 18

Study Type: INTERVENTIONAL

Condition: Diabetic Neuropathy Neuropathic Pain Neuralgia, Postherpetic

Intervention: DRUG: Experimental: Pregabalin XR

Pregabalin XR: extended-release tablet, with an initial dose of 82.5 mg once daily. The dose may be adjusted every 7 days during the first 4 weeks of ...